CONNECT WITH US:
Jun 28, 2018 07:00 JST
Novotech at DIA18 announces Asia Partnerships on Target to Reach 1.4 Bil Patients
BOSTON, Jun 28, 2018 - (ACN Newswire) - Asia-Pacific CRO Novotech announced at DIA18 (24-28 June, Boston Convention and Exhibition Center) that it has signed Memorandums of Understanding (MOUs) with five of the leading medical institutions in the region. The MOU partnership program is designed to give Novotech clients access to an additional 1.4 billion patients, and specialist investigators with advanced clinical research sites.
Novotech made the announcement at the DIA conference (Booth 1904).
Novotech Director of Business Development Barry Murphy who is attending the conference said: "Novotech has now signed five MOUs with medical institutions across the region with two more being signed in Thailand and the Philippines next month.
"Asia is the highest growth region for clinical research in the world, and as the Asia-Pacific CRO, we bring access to the key sites and KOLs to our clients via well-developed partnerships and relationships on the ground in Asia. Our MOUs further formalise these relationships.
"Some of the new MOUs are with the largest institutes in the region, such as the China Medical University Hospital in Taiwan which has more than a 2,000-bed facilities with dedicated clinical trials centres."
The partnerships are designed to give Novotech clients:
- Faster start-up times
- Access to significant patient database
- World-class clinical research - regulatory compliance with FDA, PMDA and EMEA
- Outstanding recruiters across many therapeutic areas: breast cancer, lung cancer, colorectal cancer, Hepatitis, SLE, RA, Stroke, Diabetes, etc.
- Leading principal investigators
The partnerships involve the provision of professional and medical clinical trial advice to the Novotech team including feasibility, principal investigator selection, and assistance with patient recruitment, while Novotech will promote the clinical research capabilities of these institutions internationally.
Novotech Executive Director, Asia Operations Dr. Yooni Kim said: "The partnerships mean Novotech has dedicated clinical experts within these leading hospital organisations to support and prioritise rapid clinical processes for Novotech biopharma clients.
"Novotech is the Asia-Pacific CRO, so is committed to establishing ongoing engagement with leading medical institutions in each country across the Asia-Pacific region. We have offices and teams on the ground as well as MOUs and long-term relationships with major hospitals that directly benefit our clients.
"Our in-country relationships enable a more comprehensive understanding of local regulatory changes, access to leading PIs, strong site connections, and productive patient populations to deliver success for our clients within timelines and budgets," Dr. Kim said.
Novotech is the Asia-Pacific specialist contract research organization (CRO) established in 1996, headquartered in Australia with offices in 11 countries across the region.
See the latest data on Asia clinical trials here:
About Novotech - www.novotech-cro.com
Headquartered in Sydney, Novotech is internationally recognised as the leading regional full-service contract research organisation (CRO). With a focus on clinical monitoring, Novotech has been instrumental in the success of hundreds of Phase I - IV clinical trials in the Asia Pacific region.
Novotech provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services, central lab services, report write-up to ICH requirements, project and vendor management. Novotech's strong Asia Pacific presence includes running clinical trials in all key regional markets. Novotech also has worldwide reach through the company's network of strategic partners.
For RFP enquiries: see
Novotech DIA Contact
Director of Business Development
AU: +61 2 8218 2144
USA: +1 415 951 3228
ASIA: +65 3159 3427
Copyright ©2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
Rakuten Mobile and NEC Agree to Jointly Develop Containerized Standalone 5G Core Network
Jun 03, 2020 10:34 JST
The Toyota Mobility Foundation and Partners Establish Digital Platform to Help Support People and Industry in Rural Germany
Jun 03, 2020 09:05 JST
Mitsubishi Corporation and NTT complete investment in HERE Technologies
Jun 02, 2020 14:54 JST
Toyota Announces its Line-up for the New GR Yaris in Japan
Jun 02, 2020 13:35 JST
Eisai Launches New Insomnia Drug Dayvigo (Lemborexant) CIV in the United States as a Treatment Option for Adults With Insomnia
Jun 02, 2020 11:05 JST
MHI RJ Aviation Group Launches as Mitsubishi Heavy Industries Ltd. Closes Acquisition of CRJ Series Program From Bombardier Inc.
Jun 02, 2020 10:23 JST
LEXUS previews the New IS
Jun 02, 2020 09:12 JST
DENSO and Certhon Establish DENSO AgriTech Solutions
Jun 01, 2020 12:48 JST
Fujitsu Signs Partnership Agreement with Scaled Agile, Inc., Driving Large-Scale Agile for Digital Transformation
Jun 01, 2020 12:01 JST
AbbVie and Eisai Announce an Approval for Partial Changes in the Marketing Approval of HUMIRA, a Fully Human Anti-TNFalpha Monoclonal Antibody
May 29, 2020 15:54 JST
Sharp Releases Notice of Corporate Spin-Off of the Display Device Business Division
May 29, 2020 15:47 JST
DENSO Announces Changes in the Areas of Responsibility of Senior Executive Officers and Executive Officers
May 29, 2020 12:05 JST
Eisai: Results from LENVIMA (lenvatinib) plus KEYTRUDA (pembrolizumab) Trials
May 29, 2020 11:31 JST
Hitachi Announces Change in the Effective Date for Company Split and Closing Date of Share Transfer
May 28, 2020 19:18 JST
Mitsubishi Motors Announces Production, Sales and Export Figures for April 2020
May 28, 2020 19:09 JST
Honda Sets Monthly Records for Automobile Production in China
May 28, 2020 18:52 JST
Mazda Production and Sales Results for April 2020
May 28, 2020 16:46 JST
Mazda Joins IP Open Access Declaration Against Covid-19
May 28, 2020 16:28 JST
Toyota Releases Sales, Production, and Export Results for April 2020
May 28, 2020 13:56 JST
Fujitsu Accelerates Digital Transformation with Flexible, Scale-out Software-Defined Storage ETERNUS Data Services Platform
May 28, 2020 11:26 JST
More Latest Release >>
Novotech and Endpoints to present APAC Clinical Trial webinar series
May 26 2020 19:00 JST
Novotech Selected as CRO for Karyopharm's COVID-19 Clinical Study
April 29 2020 21:00 JST
Novotech COVID-19 Clinical Trial Clients Benefit from New Asia-Pacific Fast-Track Review Processes
April 28 2020 19:00 JST
Novotech Data Shows Majority of Australian Sites are Open for Clinical Trial Activity
April 08 2020 18:00 JST
Novotech CRO Tapped for Two Informa Citeline Awards for Excellence in Asia-Pacific Clinical Trials
March 20 2020 20:30 JST
Novotech Wins CRO Contract for Komipharm Coronavirus Covid-19 Clinical Trial in South Korea
March 06 2020 22:00 JST
Asia-Pacific has Record Year for Clinical Trials says Novotech CRO
January 21 2020 10:40 JST
Novotech CRO partners Skin Research Institute of Singapore (SRIS) for Skin Disorder Research
July 11 2019 11:00 JST
Novotech Awarded Asia-Pacific Biotech CRO of the Year - Announced at ASCO
May 31 2019 07:00 JST
Novotech CRO strengthens South Korean Clinical Capabilities, partners with 2 Major Hospitals
April 18 2019 04:00 JST
More Press release >>